Edward K. Chow, Ph.D. - Publications

2007 University of California, Los Angeles, Los Angeles, CA 
Molecular Biology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mitragotri S, Anderson DG, Chen X, Chow EK, Ho D, Kabanov AV, Karp JM, Kataoka K, Mirkin CA, Petrosko SH, Shi J, Stevens MM, Sun S, Teoh S, Venkatraman SS, et al. Accelerating the Translation of Nanomaterials in Biomedicine. Acs Nano. PMID 26115196 DOI: 10.1021/acsnano.5b03569  0.36
2014 Tsai N, Lee B, Kim A, Yang R, Pan R, Lee DK, Chow EK, Ho D. Nanomedicine for global health. Journal of Laboratory Automation. 19: 511-6. PMID 24902713 DOI: 10.1177/2211068214538263  0.96
2014 Man H, Sasine J, Chow EK, Ho D. Nanodiamonds for drug delivery and diagnostics Rsc Nanoscience and Nanotechnology. 2014: 151-169.  0.96
2013 Moore L, Chow EK, Osawa E, Bishop JM, Ho D. Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression. Advanced Materials (Deerfield Beach, Fla.). 25: 3532-41. PMID 23584895 DOI: 10.1002/adma.201300343  0.96
2012 Man HB, Zhang K, Robinson E, Chow EK, Ho D. Engineering Nanoparticulate Diamond for Applications in Nanomedicine and Biology Ultrananocrystalline Diamond: Synthesis, Properties and Applications: Second Edition. 493-518. DOI: 10.1016/B978-1-4377-3465-2.00015-3  0.96
2011 Zhang XQ, Lam R, Xu X, Chow EK, Kim HJ, Ho D. Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy. Advanced Materials (Deerfield Beach, Fla.). 23: 4770-5. PMID 21932280 DOI: 10.1002/adma.201102263  0.96
2011 Smith AH, Robinson EM, Zhang XQ, Chow EK, Lin Y, Osawa E, Xi J, Ho D. Triggered release of therapeutic antibodies from nanodiamond complexes. Nanoscale. 3: 2844-8. PMID 21617824 DOI: 10.1039/c1nr10278h  0.96
2011 Ghaffari AA, Chow EK, Iyer SS, Deng JC, Cheng G. Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3. Hepatology (Baltimore, Md.). 53: 2042-52. PMID 21433044 DOI: 10.1002/hep.24316  0.96
2011 Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Science Translational Medicine. 3: 73ra21. PMID 21389265 DOI: 10.1126/scitranslmed.3001713  0.96
2010 Chen M, Zhang XQ, Man HB, Lam R, Chow EK, Ho D. Nanodiamond vectors functionalized with polyethylenimine for siRNA delivery Journal of Physical Chemistry Letters. 1: 3167-3171. DOI: 10.1021/jz1013278  0.96
2009 Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation. 119: 1910-20. PMID 19487810 DOI: 10.1172/JCI35412  0.96
2008 Chow EK, Pierstorff E, Cheng G, Ho D. Copolymeric nanofilm platform for controlled and localized therapeutic delivery. Acs Nano. 2: 33-40. PMID 19206545 DOI: 10.1021/nn7000917  0.96
2007 Chow EK, Razani B, Cheng G. Innate immune system regulation of nuclear hormone receptors in metabolic diseases. Journal of Leukocyte Biology. 82: 187-95. PMID 17314330 DOI: 10.1189/jlb.1206741  0.96
2007 Chow EK, Pierstorff E, Cheng G, Tai YC, Ho D. Attenuation of cellular inflammation using glucocorticoid-functionalized copolymers Proceedings of the 2nd Ieee International Conference On Nano/Micro Engineered and Molecular Systems, Ieee Nems 2007. 1039-1043. DOI: 10.1109/NEMS.2007.352195  0.96
2006 Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of Experimental Medicine. 203: 2589-602. PMID 17074929 DOI: 10.1084/jem.20060929  0.96
2005 Chow EK, O'connell RM, Schilling S, Wang XF, Fu XY, Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk. The Embo Journal. 24: 4071-81. PMID 16308570 DOI: 10.1038/sj.emboj.7600867  0.96
2004 Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. The Journal of Experimental Medicine. 199: 1651-8. PMID 15210743 DOI: 10.1084/jem.20040528  0.96
2004 Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G. Toll-like receptors induce a phagocytic gene program through p38. The Journal of Experimental Medicine. 199: 81-90. PMID 14699082 DOI: 10.1084/jem.20031237  0.96
2003 Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. Journal of Immunology (Baltimore, Md. : 1950). 170: 3565-71. PMID 12646618  0.96
Show low-probability matches.